OMER

Conviction 48HealthcareScan · Fri, Jun 26, 2026

OMER$8.67-19.17%

ResistanceSupportVol 14Insider sell

Vol MA14 2.66M

Mar 27Apr 15May 4May 20Jun 9Jun 26

OMEROS CORPPHARMACEUTICAL PREPARATIONSwww.omeros.com ↗

Price8.67

Change-19.17%

Gap-30.04%

Rel volume5.27×

Avg volume2.43M

Avg $ vol23.35M

SMA 2010.03

SMA 5012.06

SMA 20010.26

Price vs 50-28.16%

Price vs 200-15.52%

MA stackmixed

50/200 cross—

Supertrenddown · 11.08

RSI (14)33

MACD hist0.09

MACD crossbull · 5d

Stoch %K / %D48 / 80

ADX (14)40

+DI / −DI12 / 47

RSI divergence—

MACD divergenceBullish

ATR %+10.61%

ADR %7.65%

52w high17.18

52w low2.97

From 52w high-49.55%

Above 52w low+191.75%

New 52w highNo

SqueezeOff

Bollinger width24.21%

%B-0.06

Donchian pos44.43%

Donchian high11.12

Donchian low6.70

AVWAP (52w high)12.54

vs AVWAP high-30.91%

AVWAP (52w low)10.15

vs AVWAP low-14.59%

OBV trendDown

Chaikin MF (20)0.24

Today vs 20d5.27×

Avg vol (14d)2.66M

Avg vol (20d)2.43M

Avg $ vol (20d)23.35M

Market cap—

RS 3m (vs SPY)-9.11%

RS 6m (vs SPY)+5.50%

RS line new highNo

Trend template4/8

Technical rank9.9

1 week-15.71%

1 month-21.73%

3 months-15.87%

6 months-0.97%

1 year+147.57%

YTD-47.10%

P/E-231.39

P/B-12.24

P/S10.50

P/FCF-6.67

EPS-0.0500

Div yield—

ROE5.29%

ROA-1.17%

Debt/Eq-2.12

Current3.03

EV/EBITDA-7.45

Gross margin—

Net margin-4.54%

Rev growth-33.98%

EPS growth97.86%

Price target40.00

Target upside273.48%

Analyst ratingBuy

Institutional49.57%

Ent. value907.49M

Revenue9.89M

Net income56.06M

Gross profit—

Free cash flow-116.16M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out72.38M

Employees175

ListedThu, Oct 8, 2009

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction48 / 100

Pattern quality—

Tech rank9.9 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance13.75

Support8.13

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in OMER

All disclosures →

No recent disclosed trades by Congress in OMER. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in OMER · 8 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
HANISH ARNOLD C Director · Stock Option (Right to Buy) · 2026-06-18	Grant	15K	—	2026-06-18	2026-06-22
Bumol Thomas F. Director · Stock Option (Right to Buy) · 2026-06-18	Grant	15K	—	2026-06-18	2026-06-22
Cable Thomas J. Director · Stock Option (Right to Buy) · 2026-06-18	Grant	15K	—	2026-06-18	2026-06-22
Perkinson Diana T. Director · Stock Option (Right to Buy) · 2026-06-18	Grant	15K	—	2026-06-18	2026-06-22
Demopulos Peter A MD Director · Stock Option (Right to Buy) · 2026-06-18	Grant	15K	—	2026-06-18	2026-06-22
Hood Leroy E. MD PhD Director · Stock Option (Right to Buy) · 2026-06-18	Grant	15K	—	2026-06-18	2026-06-22
Shah Rajiv Director · Stock Option (Right to Buy) · 2026-06-18	Grant	15K	—	2026-06-18	2026-06-22
Cable Thomas J. Director · Common Stock · 2026-05-22	Exercise	7.5K	$81K	2026-05-22	2026-05-27
Cable Thomas J. Director · Common Stock · 2026-05-22	Sell	7.5K	$87K	2026-05-22	2026-05-27
Cable Thomas J. Director · Stock Option (Right to Buy) · 2026-05-22	Exercise	7.5K	$0	2026-05-22	2026-05-27

SEC filings

EDGAR filings in OMER · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.